Breakthrough Therapy Awarded to a Drug For RET-Altered Thyroid and Non-Small Cell Lung Cancers
DarkoStojanovic / Pixabay

Breakthrough Therapy Awarded to a Drug For RET-Altered Thyroid and Non-Small Cell Lung Cancers

The United States FDA has awarded Breakthrough Therapy Designation to a drug called LOXO-292 for the treatment of RET-altered non-small cell lung cancer and thyroid cancer, in patients who meet…

Continue Reading Breakthrough Therapy Awarded to a Drug For RET-Altered Thyroid and Non-Small Cell Lung Cancers

Updated Results From Cancer Drug Trial Show Greater Improvements Than Previously Reported

According to a story from Reuters, the cancer drug developer Loxo Oncology recently released the latest results from the trial testing its investigational therapy LOXO-292. Preliminary results released about a…

Continue Reading Updated Results From Cancer Drug Trial Show Greater Improvements Than Previously Reported
Nanotechnology Could Become a Breakthrough Treatment For Patients With Rare Cancers
source: pixabay.com

Nanotechnology Could Become a Breakthrough Treatment For Patients With Rare Cancers

According to a story from biospace.com, a research team from the National Cancer Institute was able to successfully deliver an experimental nanomedicine to mice that had rare cancers such as…

Continue Reading Nanotechnology Could Become a Breakthrough Treatment For Patients With Rare Cancers